Neko Health, a body scanning startup, raised $700 million in a Series C funding round, the company announced on July 15. The capital injection comes as Neko reports reaching 100,000 members and achieving profitability at the clinic level, marking a milestone in its growth trajectory, according to sifted.eu.
The funding round was led by existing and new investors, enabling Neko to expand its footprint and enhance its technology. CEO Hjalmar Nilsonne shared insights during an interview at Neko’s refurbished first clinic in Stockholm, highlighting the company’s progress in member acquisition and operational efficiency. The Series C round positions Neko to accelerate its clinic openings and technology development.
This funding round places Neko among the notable health tech startups securing large investments in 2026, reflecting growing investor interest in digital health solutions. With 100,000 members, Neko’s model of body scanning and health monitoring is gaining traction, similar to other health startups that have recently closed significant funding rounds. The profitability at the clinic level underscores the viability of its business model in a competitive market.
Neko’s next steps include scaling its clinic network and refining its scanning technology. The company’s CEO confirmed that the new funds will support these initiatives, aiming to increase member base and service offerings. The Series C round was publicly disclosed on July 15, 2026, marking a key development in Neko Health’s expansion.